| http://www.w3.org/ns/prov#value | - Thus, IKKepsilon may represent an attractive therapeutic target for obesity, insulin resistance, diabetes, and other complications associated with these disorders.Comment inIkappaB kinase epsilon: a potential therapeutic target for obesity (and nonalcoholic fatty liver disease)? [Hepatology. 2010]IKKepsilon: a bridge between obesity and inflammation. [Cell. 2009]PMID: 19737522 [PubMed - indexed fo
|
